Division of Psychiatry, UCL, London, UK.
Division of Psychology and Language Sciences, UCL, London, UK.
BMJ Open. 2022 Mar 9;12(3):e053943. doi: 10.1136/bmjopen-2021-053943.
To investigate the extent of antipsychotic prescribing to people with recorded personality disorder (PD) in UK primary care and factors associated with such prescribing.
Retrospective cohort study.
General practices contributing to The Health Improvement Network UK-wide primary care database, 1 January 2000-31 December 2016.
46 210 people registered with participating general practices who had a record of PD in their general practice notes. 1358 (2.9%) people with missing deprivation information were excluded from regression analyses; no other missing data.
Prescriptions for antipsychotics in general practice records and length of time in receipt of antipsychotic prescriptions.
Of 46 210 people with recorded PD, 15 562 (34%) were ever prescribed antipsychotics. Among the subgroup of 36 875 people with recorded PD, but no recorded severe mental illness (SMI), 9208 (25%) were prescribed antipsychotics; prescribing was lower in less deprived areas (adjusted rate ratio (aRR) comparing least to most deprived quintile: 0.56, 95% CI 0.48 to 0.66, p<0.001), was higher in females (aRR:1.25, 95% CI 1.16 to 1.34, p<0.001) and with a history of adverse childhood experiences (aRR:1.44, 95% CI 1.28 to 1.56, p<0.001). Median time prescribed antipsychotics was 605 days (IQR 197-1639 days). Prescribing frequency has increased over time.
Contrary to current UK guidelines, antipsychotics are frequently and increasingly prescribed for extended periods to people with recorded PD, but with no history of SMI. An urgent review of clinical practice is warranted, including the effectiveness of such prescribing and the need to monitor for adverse effects, including metabolic complications.
调查英国初级保健中记录有精神分裂症患者的抗精神病药物处方情况,以及与处方相关的因素。
回顾性队列研究。
2000 年 1 月 1 日至 2016 年 12 月 31 日,参与英国全民医疗保健网络的普通实践贡献者。
46210 名在参与的普通实践中注册,在普通实践记录中有精神分裂症记录的人。有 1358 人(2.9%)的人因缺乏贫困信息而被排除在回归分析之外;没有其他数据缺失。
普通实践记录中的抗精神病药物处方和接受抗精神病药物处方的时间长度。
在 46210 名记录有精神分裂症的患者中,有 15562 人(34%)曾被处方抗精神病药物。在 36875 名记录有精神分裂症但无记录有严重精神疾病的患者中,有 9208 人(25%)被处方抗精神病药物;在贫困程度较低的地区(比较最不富裕到最富裕的五分位数的调整率比(aRR):0.56,95%CI 0.48 至 0.66,p<0.001),女性(aRR:1.25,95%CI 1.16 至 1.34,p<0.001)和有不良童年经历的患者(aRR:1.44,95%CI 1.28 至 1.56,p<0.001)的处方率更高。抗精神病药物处方的中位数时间为 605 天(IQR 197-1639 天)。处方频率随时间推移而增加。
与当前英国指南相反,经常且越来越多地为记录有精神分裂症但无严重精神疾病史的患者开处抗精神病药物,且处方时间较长。需要紧急审查临床实践,包括这种处方的有效性和监测不良反应的必要性,包括代谢并发症。